Xavier Troussard

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 15

Top Venues

Clinical case reports

American journal of hematology

Cancer reports (Hoboken, N.J.)

Cancer medicine

CHU Cote de Nacre

This page only lists publications with an associated author ORCID identifier.

Affiliation History

CHU Cote de Nacre Sep 1o 1977

France

Directeur Général :: Direction Générale

Publications

Laura Cailly, Cécile Gruchet, Elsa Maitre, Stephanie Guidez, Vincent Delwail, Thomas Systchenko, Niels Moya, Florence Sabirou, Anthony Levy, Arthur Bobin, Hélène Gardeney, Laly Nsiala, Mathilde Vonfeld, Aurélia Chacon, Aurélien Pichon, Sabrina Bouyer, Caroline Baslé, Elodie Dindinnaud, Jean-Claude Chomel, Anna Raimbault, Florence Borde-Mougenot, Xavier Troussard, Cécile Tomowiak
Hairy cell leukemia with isolated bone lesions. Clinical case reports 11 (5) (2023)
Laura Cailly, Cécile Gruchet, Elsa Maitre, Stephanie Guidez, Vincent Delwail, Thomas Systchenko, Niels Moya, Florence Sabirou, Anthony Levy, Arthur Bobin, Hélène Gardeney, Laly Nsiala, Mathilde Vonfeld, Aurélia Chacon, Aurélien Pichon, Sabrina Bouyer, Caroline Baslé, Elodie Dindinnaud, Jean-Claude Chomel, Anna Raimbault, Florence Borde-Mougenot, Xavier Troussard, Cécile Tomowiak
Hairy cell leukemia with isolated bone lesions. Clinical case reports 11 (5) (2023)
Laura Cailly, Cécile Gruchet, Elsa Maitre, Stephanie Guidez, Vincent Delwail, Thomas Systchenko, Niels Moya, Florence Sabirou, Anthony Levy, Arthur Bobin, Hélène Gardeney, Laly Nsiala, Mathilde Vonfeld, Aurélia Chacon, Aurélien Pichon, Sabrina Bouyer, Caroline Baslé, Elodie Dindinnaud, Jean-Claude Chomel, Anna Raimbault, Florence Borde-Mougenot, Xavier Troussard, Cécile Tomowiak
Hairy cell leukemia with isolated bone lesions. Clinical case reports 11 (5) (2023)
Christian Buske, Meletios- Athanasios Dimopoulos, Alexander Grunenberg, Efstathios Kastritis, Cécile Tomowiak, Béatrice Mahé, Xavier Troussard, Roman Hájek, Andreas Viardot, Olivier Tournilhac, Therese Aurran, Stephane Lepretre, Hacene Zerazhi, Benedicte Hivert, Veronique Leblond, Sophie de Guibert, Lena Brandefors, Miriam Santero, Maria Gomes da Silva, Eva Kimby, Birgit Schmelzle, Dajana Kaszynski, Jens Dreyhaupt, Rainer Muche, Pierre Morel
Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's Macroglobulinemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Kueshivi Midodji Atsou, Bernard Rachet, Edouard Cornet, Marie-Lorraine Chretien, Cédric Rossi, Laurent Remontet, Laurent Roche, Roch Giorgi, Sophie Gauthier, Stéphanie Girard, Johann Böckle, Stéphane Kroudia Wasse, Helene Rachou, Laila Bouzid, Jean-Marc Poncet, Sébastien Orazio, Alain Monnereau, Xavier Troussard, Morgane Mounier, Marc Maynadié
Factors influencing access to specialised haematology units during acute myeloblastic leukaemia patient care: A population-based study in France. Cancer medicine (2023)
Elsa Maître, Margaret Macro, Xavier Troussard
Hairy cell leukaemia with unusual BRAF mutations. Journal of cellular and molecular medicine (2023)
Jérôme Paillassa, Elsa Maitre, Xavier Troussard
Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances. Current oncology reports 24 (9) (2022)
Vincent Akiki, Xavier Troussard, Jean-Phillippe Metges, Patrick Devos
Global trends in oncology research: A mixed-methods study of publications and clinical trials from 2010 to 2019. Cancer reports (Hoboken, N.J.) (2022)
Jérôme Paillassa, Firas Safa, Xavier Troussard
Updates in hairy cell leukemia (HCL) and variant-type HCL (HCL-V): rationale for targeted treatments with a focus on ibrutinib. Therapeutic advances in hematology 13 (2022)
Xavier Troussard, Elsa Maître, Edouard Cornet
Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment. American journal of hematology (2021)
Jérôme Paillassa, Xavier Troussard
Patients with relapsed/refractory hairy-cell leukemia. Cancer reports (Hoboken, N.J.) (2021)
Jim Canet, Pascale Cony-Makhoul, Sébastien Orazio, Edouard Cornet, Xavier Troussard, Marc Maynadié, Gabriel Etienne, Alain Monnereau
Second- or third-generation tyrosine kinase inhibitors in first-line treatment of chronic myeloid leukemia in general population: Is there a real benefit? Cancer medicine 10 (20) (2021)
Elsa Maitre, Edouard Cornet, Xavier Troussard
Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment. American journal of hematology 94 (12) (2019)
Simon Body, Anna Esteve-Arenys, Clara Recasens-Zorzo, Xavier Troussard, Gael Roué, Brigitte Sola
A mouse model of disseminated mantle cell lymphoma highlights a lack of activity of estrogen receptor β agonists toward tumor burden. Leukemia & lymphoma 59 (7) (2017)
Xavier Troussard, Edouard Cornet
Hairy cell leukemia 2018: Update on diagnosis, risk-stratification, and treatment. American journal of hematology 92 (12) (2017)

Xavier Troussard.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xavier Troussard